• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症与帕金森病发病机制。

Inflammation and Parkinson's disease pathogenesis.

机构信息

Department of Neurology, Pathology and Cell Biology, Columbia University, New York, New York, USA.

出版信息

Mov Disord. 2010;25 Suppl 1:S55-7. doi: 10.1002/mds.22638.

DOI:10.1002/mds.22638
PMID:20187228
Abstract

Inflammation is a neuropathological feature of parkinsonian brains and also in experimental models of the disease. It is believed that activated glial cells, which compose the majority of this inflammatory response contribute to the neurodegenerative process through the production of toxic molecules. Therapeutic strategies geared toward reducing inflammation and inhibiting the production of these glial-derived toxic molecules may be a promising neuroprotective strategy for the treatment of Parkinson's disease and related conditions.

摘要

炎症是帕金森病患者大脑的神经病理学特征,也是该疾病实验模型中的特征。人们认为,构成这种炎症反应主要部分的活化神经胶质细胞通过产生毒性分子,促成了神经退行性过程。针对减轻炎症和抑制这些源自神经胶质的毒性分子产生的治疗策略,可能是治疗帕金森病和相关疾病的一种很有前途的神经保护策略。

相似文献

1
Inflammation and Parkinson's disease pathogenesis.炎症与帕金森病发病机制。
Mov Disord. 2010;25 Suppl 1:S55-7. doi: 10.1002/mds.22638.
2
[Inflammation and Parkinson's disease].[炎症与帕金森病]
Rev Neurol. 2004;38(6):545-53.
3
Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.雌激素、神经炎症与帕金森病中的神经保护:神经胶质细胞决定对神经退行性变的抵抗与易感性
Neuroscience. 2006;138(3):869-78. doi: 10.1016/j.neuroscience.2005.07.060. Epub 2005 Dec 5.
4
Glial reactions in Parkinson's disease.帕金森病中的胶质反应。
Mov Disord. 2008 Mar 15;23(4):474-83. doi: 10.1002/mds.21751.
5
Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway.激素是基因与环境相互作用中编程帕金森病易感性的关键因素:胶质细胞作为共同的最终途径。
Ann N Y Acad Sci. 2005 Dec;1057:296-318. doi: 10.1196/annals.1356.023.
6
The effect of repetitive transcranial magnetic stimulation on a model rat of Parkinson's disease.重复经颅磁刺激对帕金森病模型大鼠的影响。
Neuroreport. 2010 Mar 10;21(4):268-72. doi: 10.1097/WNR.0b013e328335b411.
7
Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.醋酸格拉替雷可能因其神经保护和抗炎作用而成为帕金森病的一种潜在治疗药物。
Med Hypotheses. 2007;69(6):1219-21. doi: 10.1016/j.mehy.2007.04.014. Epub 2007 Jun 4.
8
Inflammation and neurodegeneration in Parkinson's disease.帕金森病中的炎症与神经退行性变
Parkinsonism Relat Disord. 2004 May;10 Suppl 1:S3-7. doi: 10.1016/j.parkreldis.2004.01.005.
9
Role of inflammation in the pathogenesis of Parkinson's disease: models, mechanisms, and therapeutic interventions.炎症在帕金森病发病机制中的作用:模型、机制及治疗干预
Ann N Y Acad Sci. 2005 Aug;1053:151-2. doi: 10.1196/annals.1344.054.
10
Inflammation in Parkinson's disease.帕金森病中的炎症
J Neurol. 2003 Feb;250 Suppl 1:I35-8. doi: 10.1007/s00415-003-1107-x.

引用本文的文献

1
Natural Neuroinflammatory Modulators: Therapeutic Potential of Fungi-Derived Compounds in Selected Neurodegenerative Diseases.天然神经炎症调节剂:真菌衍生化合物在特定神经退行性疾病中的治疗潜力
Molecules. 2025 Jul 28;30(15):3158. doi: 10.3390/molecules30153158.
2
Function and Mechanism of Abscisic Acid on Microglia-Induced Neuroinflammation in Parkinson's Disease.脱落酸对帕金森病中小胶质细胞诱导的神经炎症的作用及其机制。
Int J Mol Sci. 2024 Apr 30;25(9):4920. doi: 10.3390/ijms25094920.
3
Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases.
小胶质细胞在神经退行性疾病发展过程中对衰老和神经炎症的反应。
Neural Regen Res. 2024 Jun 1;19(6):1241-1248. doi: 10.4103/1673-5374.385845. Epub 2023 Sep 22.
4
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease.CRISPR/Cas9辅助干细胞疗法治疗帕金森病
Biomater Res. 2023 May 16;27(1):46. doi: 10.1186/s40824-023-00381-y.
5
"Reframing" dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications.在衰老帕金森病大脑的神经胶质网络交汇处重新构建多巴胺信号作为先天 Nrf2/Wnt 驱动器:治疗意义。
Aging Cell. 2022 Apr;21(4):e13575. doi: 10.1111/acel.13575. Epub 2022 Mar 9.
6
Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson's Disease.细胞外囊泡作为帕金森病新型诊断和预后生物标志物
Aging Dis. 2021 Sep 1;12(6):1494-1515. doi: 10.14336/AD.2021.0527. eCollection 2021 Sep.
7
Treating Parkinson's Disease with Antibodies: Previous Studies and Future Directions.用抗体治疗帕金森病:既往研究与未来方向。
J Parkinsons Dis. 2021;11(1):71-92. doi: 10.3233/JPD-202221.
8
Pharmacological Treatment of Early Motor Manifestations of Parkinson Disease (PD).帕金森病(PD)早期运动症状的药物治疗。
Neurotherapeutics. 2020 Oct;17(4):1331-1338. doi: 10.1007/s13311-020-00924-4. Epub 2020 Sep 15.
9
Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease.Nrf2/Wnt 弹性协调帕金森病中神经胶质-神经元对话的年轻化。
Redox Biol. 2020 Sep;36:101664. doi: 10.1016/j.redox.2020.101664. Epub 2020 Aug 1.
10
Glia-Derived Extracellular Vesicles in Parkinson's Disease.帕金森病中的胶质细胞衍生细胞外囊泡
J Clin Med. 2020 Jun 21;9(6):1941. doi: 10.3390/jcm9061941.